Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_3

80%

Ph phase_4

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 3Large-scale testing

4(80.0%)

Phase 4Post-market surveillance

1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(4)

Other(1)

Detailed Status

Completed4

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 34 (80.0%)

Phase 41 (20.0%)

Trials by Status

completed480%

unknown120%

Recent Activity

0 active trials

Showing 5 of 5

completedphase_3

To Assess the Efficacy and Safety of Dual Anticoagulants i.e. Rivaroxaban Plus Aspirin and Clopidogrel Plus Aspirin in Patients Suffering From an Acute Coronary Syndrome

NCT05573958

Clinical Trials (5)

Showing 5 of 5 trials

NCT06037889Phase 3

Efficacy and Safety of Tirofiban for Patients With BAD (BRANT)

Completed

NCT06242132Phase 3

Clopidogrel Versus Cilostazol in Ischemic Stroke

Completed

NCT06242145Phase 3

Clopidogrel Versus Cilostazol in Large-vessel Ischemic Stroke

Completed

NCT05553613Phase 3

Ticagrelor Versus Clopidogrel in Ischemic Stroke

Completed

NCT05573958Phase 4

To Assess the Efficacy and Safety of Dual Anticoagulants i.e. Rivaroxaban Plus Aspirin and Clopidogrel Plus Aspirin in Patients Suffering From an Acute Coronary Syndrome

Unknown

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5